BARING ASSET MANAGEMENT Ltd Acquires Shares of 4,276 Medtronic PLC (MDT)

BARING ASSET MANAGEMENT Ltd acquired a new position in shares of Medtronic PLC (NYSE:MDT) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 4,276 shares of the medical technology company’s stock, valued at approximately $380,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Parkside Financial Bank & Trust increased its stake in shares of Medtronic PLC by 22.4% during the 2nd quarter. Parkside Financial Bank & Trust now owns 1,146 shares of the medical technology company’s stock worth $102,000 after purchasing an additional 210 shares in the last quarter. Farmers National Bank purchased a new position in shares of Medtronic PLC during the 1st quarter worth approximately $121,000. Norway Savings Bank increased its stake in shares of Medtronic PLC by 2.7% during the 2nd quarter. Norway Savings Bank now owns 1,427 shares of the medical technology company’s stock worth $127,000 after purchasing an additional 38 shares in the last quarter. Israel Discount Bank of New York purchased a new position in shares of Medtronic PLC during the 1st quarter worth approximately $117,000. Finally, Birch Hill Investment Advisors LLC purchased a new position in shares of Medtronic PLC during the 1st quarter worth approximately $120,000. 80.63% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: “BARING ASSET MANAGEMENT Ltd Acquires Shares of 4,276 Medtronic PLC (MDT)” was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this article on another website, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this article can be accessed at https://ledgergazette.com/2017/10/09/baring-asset-management-ltd-acquires-shares-of-4276-medtronic-plc-mdt.html.

In other Medtronic PLC news, CEO Omar Ishrak sold 140,407 shares of the company’s stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $81.63, for a total value of $11,461,423.41. Following the transaction, the chief executive officer now owns 668,503 shares in the company, valued at approximately $54,569,899.89. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Bryan C. Hanson sold 12,000 shares of the company’s stock in a transaction that occurred on Monday, July 17th. The shares were sold at an average price of $88.57, for a total transaction of $1,062,840.00. The disclosure for this sale can be found here. 0.31% of the stock is currently owned by corporate insiders.

Medtronic PLC (NYSE MDT) opened at 79.81 on Monday. Medtronic PLC has a one year low of $69.35 and a one year high of $89.72. The firm has a market cap of $108.11 billion, a price-to-earnings ratio of 26.86 and a beta of 1.01. The firm has a 50 day moving average of $80.14 and a 200-day moving average of $83.32.

Medtronic PLC (NYSE:MDT) last released its quarterly earnings data on Tuesday, August 22nd. The medical technology company reported $1.12 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.08 by $0.04. The firm had revenue of $7.39 billion for the quarter, compared to analyst estimates of $7.44 billion. Medtronic PLC had a net margin of 13.75% and a return on equity of 12.92%. The company’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.03 EPS. Equities research analysts forecast that Medtronic PLC will post $4.77 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 20th. Shareholders of record on Friday, September 29th will be paid a $0.46 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $1.84 annualized dividend and a yield of 2.31%. Medtronic PLC’s dividend payout ratio is presently 61.95%.

Medtronic PLC declared that its board has authorized a stock buyback plan on Friday, June 23rd that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the medical technology company to buy up to 49% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s board believes its shares are undervalued.

A number of research analysts have recently weighed in on MDT shares. BidaskClub raised shares of Medtronic PLC from a “buy” rating to a “strong-buy” rating in a research note on Saturday, June 17th. William Blair reissued an “outperform” rating on shares of Medtronic PLC in a research note on Thursday, July 6th. Wells Fargo & Company reissued an “outperform” rating on shares of Medtronic PLC in a research note on Wednesday, July 12th. Oppenheimer Holdings, Inc. reissued a “buy” rating on shares of Medtronic PLC in a research note on Tuesday, July 18th. Finally, Deutsche Bank AG set a $96.00 price objective on shares of Medtronic PLC and gave the stock a “buy” rating in a research note on Monday, July 31st. Three investment analysts have rated the stock with a sell rating, nine have issued a hold rating and fourteen have given a buy rating to the company. Medtronic PLC presently has an average rating of “Hold” and an average price target of $88.98.

About Medtronic PLC

Medtronic Publ

Other institutional investors and hedge funds have also modified their holdings of the company. Parkside Financial Bank & Trust increased its stake in shares of Medtronic PLC by 22.4% during the 2nd quarter. Parkside Financial Bank & Trust now owns 1,146 shares of the medical technology company’s stock worth $102,000 after purchasing an additional 210 shares in the last quarter. Farmers National Bank purchased a new position in shares of Medtronic PLC during the 1st quarter worth approximately $121,000. Norway Savings Bank increased its stake in shares of Medtronic PLC by 2.7% during the 2nd quarter. Norway Savings Bank now owns 1,427 shares of the medical technology company’s stock worth $127,000 after purchasing an additional 38 shares in the last quarter. Israel Discount Bank of New York purchased a new position in shares of Medtronic PLC during the 1st quarter worth approximately $117,000. Finally, Birch Hill Investment Advisors LLC purchased a new position in shares of Medtronic PLC during the 1st quarter worth approximately $120,000. 80.63% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: “BARING ASSET MANAGEMENT Ltd Acquires Shares of 4,276 Medtronic PLC (MDT)” was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this article on another website, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this article can be accessed at https://ledgergazette.com/2017/10/09/baring-asset-management-ltd-acquires-shares-of-4276-medtronic-plc-mdt.html.

In other Medtronic PLC news, CEO Omar Ishrak sold 140,407 shares of the company’s stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $81.63, for a total value of $11,461,423.41. Following the transaction, the chief executive officer now owns 668,503 shares in the company, valued at approximately $54,569,899.89. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Bryan C. Hanson sold 12,000 shares of the company’s stock in a transaction that occurred on Monday, July 17th. The shares were sold at an average price of $88.57, for a total transaction of $1,062,840.00. The disclosure for this sale can be found here. 0.31% of the stock is currently owned by corporate insiders.

Medtronic PLC (NYSE MDT) opened at 79.81 on Monday. Medtronic PLC has a one year low of $69.35 and a one year high of $89.72. The firm has a market cap of $108.11 billion, a price-to-earnings ratio of 26.86 and a beta of 1.01. The firm has a 50 day moving average of $80.14 and a 200-day moving average of $83.32.

Medtronic PLC (NYSE:MDT) last released its quarterly earnings data on Tuesday, August 22nd. The medical technology company reported $1.12 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.08 by $0.04. The firm had revenue of $7.39 billion for the quarter, compared to analyst estimates of $7.44 billion. Medtronic PLC had a net margin of 13.75% and a return on equity of 12.92%. The company’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.03 EPS. Equities research analysts forecast that Medtronic PLC will post $4.77 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 20th. Shareholders of record on Friday, September 29th will be paid a $0.46 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $1.84 annualized dividend and a yield of 2.31%. Medtronic PLC’s dividend payout ratio is presently 61.95%.

Medtronic PLC declared that its board has authorized a stock buyback plan on Friday, June 23rd that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the medical technology company to buy up to 49% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s board believes its shares are undervalued.

A number of research analysts have recently weighed in on MDT shares. BidaskClub raised shares of Medtronic PLC from a “buy” rating to a “strong-buy” rating in a research note on Saturday, June 17th. William Blair reissued an “outperform” rating on shares of Medtronic PLC in a research note on Thursday, July 6th. Wells Fargo & Company reissued an “outperform” rating on shares of Medtronic PLC in a research note on Wednesday, July 12th. Oppenheimer Holdings, Inc. reissued a “buy” rating on shares of Medtronic PLC in a research note on Tuesday, July 18th. Finally, Deutsche Bank AG set a $96.00 price objective on shares of Medtronic PLC and gave the stock a “buy” rating in a research note on Monday, July 31st. Three investment analysts have rated the stock with a sell rating, nine have issued a hold rating and fourteen have given a buy rating to the company. Medtronic PLC presently has an average rating of “Hold” and an average price target of $88.98.

About Medtronic PLC

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT).

Institutional Ownership by Quarter for Medtronic PLC (NYSE:MDT)

Receive News & Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply